Antiplatelet Therapy is Recommended for Vertebral Artery Dissection with Infarcts
For a 32-year-old male with vertebral artery dissection and infarcts, initiate antiplatelet therapy with either aspirin (75-325 mg daily), clopidogrel (75 mg daily), or aspirin plus extended-release dipyridamole (25/200 mg twice daily). These options are equally acceptable and preferred over anticoagulation 1, 2.
Evidence-Based Rationale
The 2011 ASA/ACCF/AHA guidelines provide Class I, Level B recommendations that antiplatelet therapy is appropriate for patients with vertebral artery atherosclerosis who have sustained ischemic stroke or TIA 1, 2. While these guidelines primarily address atherosclerotic disease, they establish the framework for vertebral artery pathology with ischemic events.
The landmark CADISS trial (2015) directly compared antiplatelet versus anticoagulation therapy in cervical artery dissection patients and found no difference in efficacy 3. Among 250 patients with carotid and vertebral dissection:
- Stroke recurrence was rare in both groups (only 4 of 250 patients, or 2%)
- Ipsilateral stroke or death occurred in 2% of antiplatelet patients versus 1% of anticoagulation patients (not statistically significant, p=0.63)
- One major bleeding event (subarachnoid hemorrhage) occurred in the anticoagulation group
- No deaths occurred in either group
The 2021 European Stroke Organisation guideline reinforces this, strongly recommending that clinicians can prescribe either antiplatelet or anticoagulation therapy in acute symptomatic extracranial artery dissection, as phase 2 RCTs showed no difference in benefits or risks 4.
Specific Medication Regimen Options
Choose one of the following based on patient tolerance, cost, and contraindications:
- Aspirin 81-325 mg daily (simplest, most cost-effective)
- Clopidogrel 75 mg daily (if aspirin contraindicated or not tolerated) 2
- Aspirin 25 mg + extended-release dipyridamole 200 mg twice daily (may offer slight advantage over aspirin alone in general stroke prevention) 2
Avoid dual antiplatelet therapy (aspirin + clopidogrel) as it increases hemorrhage risk without proven benefit 2.
Duration and Follow-up
- Continue antiplatelet therapy for at least 3-6 months initially 3
- Serial noninvasive imaging (MRA or CTA) is reasonable to assess vessel healing and exclude progression 1
- Most dissections heal within 3-6 months, though some may show persistent intimal flaps even with clinical stability 5
- Long-term antiplatelet therapy is typically continued indefinitely for secondary stroke prevention
Critical Pitfalls to Avoid
Do not use anticoagulation routinely. While historically some clinicians favored anticoagulation for dissection, the CADISS trial definitively showed no superiority, and anticoagulation carries bleeding risk 3. Reserve anticoagulation only if the patient has a separate indication (e.g., atrial fibrillation, mechanical heart valve) 2.
Do not assume high recurrence risk. Older observational studies suggested high stroke recurrence rates, but CADISS demonstrated actual recurrence is rare (2%), much lower than previously reported 3. This finding was confirmed in other studies showing recurrent ischemic events are uncommon regardless of antithrombotic choice 6.
Ensure accurate diagnosis. In CADISS, central imaging review failed to confirm dissection in 52 of 250 patients (21%), indicating radiographic criteria are frequently misapplied in clinical practice 3. High-resolution vessel wall imaging (MRI) can help confirm intramural hematoma and intimal flap.
Additional Management Considerations
- Blood pressure control is essential, as hypertension is strongly associated with vertebral artery disease 2
- Lifestyle modification and atherosclerotic risk factor management should follow standards for extracranial cerebrovascular disease 1
- Thrombolysis is not contraindicated if the patient presents within the appropriate time window for acute stroke treatment 4, 7
- Consider screening for underlying arteriopathy (fibromuscular dysplasia, connective tissue disorders) in young patients with spontaneous dissection
The evidence strongly supports antiplatelet therapy as first-line treatment, with aspirin being the most straightforward choice for this 32-year-old male with vertebral artery dissection and infarcts.